# Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics

> **NCT00656604** · NA · COMPLETED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **GENETIC:** proteomic profiling
- **PROCEDURE:** lumpectomy or mastectomy
- **PROCEDURE:** dynamic contrast-enhanced magnetic resonance imaging
- **PROCEDURE:** histopathologic examination
- **PROCEDURE:** magnetic resonance spectroscopy

## Key facts

- **NCT ID:** NCT00656604
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2005-10
- **Final completion:** 2008-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2013-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00656604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00656604, "Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00656604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*